Bioresponsive mesoporous silica nanoparticles for triggered drug release. - Wikidata - wikimedia - TriplyDB

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

http://www.wikidata.org/entity/Q42597124

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns Mitochondria-Mediated Protein Regulation Mechanism of Polymorphs-Dependent Inhibition of Nanoselenium on Cancer Cells Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response.Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.Enzyme-directed assembly of a nanoparticle probe in tumor tissue Facile fabrication of a near-infrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer therapy.Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery.An endoscope with integrated transparent bioelectronics and theranostic nanoparticles for colon cancer treatment.Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants.Silica-based mesoporous nanoparticles for controlled drug delivery.Functioning of nanovalves on polymer coated mesoporous silica Nanoparticles.Biological stimuli and biomolecules in the assembly and manipulation of nanoscale polymeric particles.Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.Smart Mesoporous Nanomaterials for Antitumor Therapy.Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.Polymer-based stimuli-responsive nanosystems for biomedical applications.MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.Triggered Nanoparticles as Therapeutics.Smart drug delivery systems: from fundamentals to the clinic.The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Smart Polymeric Nanoparticles as Emerging Tools for Imaging--The Parallel Evolution of Materials.Advanced Functional Nanomaterials for Theranostics.Engineered Materials for Cancer Immunotherapy.Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Clotting activity of polyphosphate-functionalized silica nanoparticles.Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy.Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs.Recent Advance on Mesoporous Silica Nanoparticles-Based Controlled Release System: Intelligent Switches Open up New Horizon.Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.

P2860

Q26745710-B2AB5C48-A02A-42A0-AF4C-8175BBED5169 Q28396462-A8ABDE54-8823-411C-BD57-7C46A05B07A1 Q28597927-9CEF4A11-5273-44F1-87F5-81EF414EB7E0 Q30445141-5C617789-176D-4FC0-92B8-DD8BA6BA9F0F Q33862903-F5FFDBB4-18D8-4EAC-BCD9-DD3C2C7E17C4 Q33940322-157318AD-444B-4C67-9B31-59071A24298C Q35192974-A38B9911-6E35-43CD-8D4F-51092F4074DF Q35921552-7F792EE3-8EBE-415A-9ADF-7FA6A7FD5E13 Q36318382-FBD78023-D4FE-4DF2-BBCF-D4E6B6C8303F Q36360672-8625B6AA-0F7E-4B21-BD2A-A4BD4281C456 Q36943671-B45B6852-CA30-4320-BB2F-6FCC28495438 Q37151406-F8925203-1F04-48CA-85B9-DCFF5C7BB521 Q37389967-10E4CFCE-8207-4C4C-9F5D-F6884C4E6DA4 Q37396540-AB929CF5-562B-4ABF-B72E-7280669147D8 Q37538055-241F3975-AFD0-46C8-A866-EC43E2EABFFF Q37624164-E39ECF96-B900-4255-9115-9CEEFB1F50D8 Q37638621-C10D9D9B-5635-4AD0-A0E6-FD8233816D46 Q38002853-14412567-807C-4CDA-B406-069DA86837B5 Q38120724-1CAEFD81-3626-4F7E-B661-CA18324C5DA8 Q38154210-5EA6CE44-5EB9-41EA-B171-E7065C1DC4B8 Q38155500-334974AA-BCB8-44DB-AAA3-A4A861A547AE Q38210020-35AED8CB-78FF-44FD-852D-709641F9CA72 Q38215663-6900FEAE-B815-47FE-AFE4-BEE5A75311F9 Q38271137-7B208DDD-EE0B-4ABD-8B58-ECF8B94B98B5 Q38491805-0E033C5B-8C6F-4406-B485-3ACDD000F29F Q38632193-B5884313-1112-433E-8DE1-BFDB6629051B Q38639877-A003F8F7-2D0B-4CA1-8975-1A9A760E70A0 Q38660577-4957936A-7E89-46D8-9007-26615AC47D22 Q38685860-D0F4A8AA-DED5-48D8-99AB-83FD7214980A Q38712927-34F7867B-124C-4C85-89D6-531D64EAB54B Q38780297-1B8AE61F-3A0A-4D22-BB27-838A3A5F79FD Q38827516-9A4907EC-999E-4B28-87E6-1650997691CE Q38845465-8C913605-29B0-42FC-B6BF-7EBF1AB3569A Q38893527-7865F06B-3694-4D53-88FC-45B660D5F084 Q38920823-52A0D44D-ED1C-42D5-B8F8-01062C613816 Q38932275-92F3A6D8-C01B-4655-949E-1C083C289E40 Q38956634-B73E5EB6-4ED7-4BB1-9E76-8C529EDCFE1B Q39036109-356713F7-6E4C-4397-9BF5-D7D7E950633B Q39202711-636A2EA1-9637-462C-A003-AE45C8EF2F51 Q39213207-51069EBA-9C5B-4F26-9679-2EB92EFABB72

P2860

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

http://www.wikidata.org/entity/Q42597124

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@en

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@nl

type

label

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@en

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@nl

prefLabel

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@en

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@nl

P1433

Q42597124-5336A2E0-8370-4703-A106-E33EDA5EEC68

P1476

Q42597124-E6D5BF61-2A1E-45C4-AFD1-ED1E6A35EFE3

P2093

Q42597124-28E73DED-C15D-475B-9691-1BA78A3C7FAD

Q42597124-2F30AF3C-2209-400F-A507-1DFACF30EB74

Q42597124-5655A8EF-AE33-4433-AF7F-4EFD17B5F425

Q42597124-7727457C-BEF2-4F70-B89B-975152E23CFC

Q42597124-8B324675-E3D7-47E7-9FDF-58BF6DF51DEC

Q42597124-EAD796D8-8B7A-46A6-891F-B77711FBE6B7

Q42597124-F34AD729-20E9-4A5E-B000-C9183CBDF63E

P2860

Q42597124-087220FB-67F7-455E-97EE-ECD195227ACD

Q42597124-20969655-DACB-4461-B86F-4E18F23B2753

Q42597124-3086137A-0B88-49D8-8777-ACAA317B873D

Q42597124-320F1B3B-3370-47A9-909E-FB23E4C9CAF2

Q42597124-4B8268E7-DB6F-48A3-A2A3-8F12D05562A2

Q42597124-4E4290A1-BB98-423E-9633-38F8DAEDB99D

Q42597124-64152088-7749-447D-8E0C-D5DC16373019

Q42597124-6F159046-C913-47E3-93B7-0ACFED1B2815

Q42597124-707796B1-AED1-4A19-94D2-FB230479496F

Q42597124-7B76C3D1-6AE5-41EB-BCAF-0B2766C7A262

P304

Q42597124-003E29A5-5898-428C-852E-7CF4A39C0EA7

P31

Q42597124-393E0A9D-5D71-4053-9441-5B649D081ECF

P356

Q42597124-B861734E-17D8-45EC-9EF4-3EE206718546

P407

Q42597124-1ED383EF-E9EB-4B46-AA69-3DC3FFDE38EF

P433

Q42597124-CAA09CA7-59C9-499C-8883-21256AB3D62B

P478

Q42597124-DEB40945-A7E7-42B9-958F-963FAF71C3DB

P50

Q42597124-2CA4A6B6-61EF-4F59-B640-BE2A55492BAA

P577

Q42597124-7C93AC20-36EA-4AB1-8CBE-3BA708BCA84F

P5875

Q42597124-4D3842EC-8A94-46FD-9AA4-C5DAC733988E

P698

Q42597124-28384A75-2240-4292-BF37-FDBF9DD65677

P921

Q42597124-7858820B-4A72-4983-9824-233564D48F74

P932

Q42597124-0B0FD6B6-D2BD-4DBA-85B0-D728A1CBFABC

P356

P1433

Journal of the American Chemical Society

P1476

Bioresponsive mesoporous silica nanoparticles for triggered drug release.

@en

P2093

Amrita Karambelkar

http://www.w3.org/2001/XMLSchema#string

Jordan S Miller

http://www.w3.org/2001/XMLSchema#string

Kevin Lin

http://www.w3.org/2001/XMLSchema#string

Luo Gu

http://www.w3.org/2001/XMLSchema#string

Michael J Sailor

http://www.w3.org/2001/XMLSchema#string

Neetu Singh

http://www.w3.org/2001/XMLSchema#string

Sangeeta N Bhatia

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release

Bioactive hydrogels made from step-growth derived PEG-peptide macromers

Shell click-crosslinked (SCC) nanoparticles: a new methodology for synthesis and orthogonal functionalization.

Gold nanocages covered by smart polymers for controlled release with near-infrared light.

Nanotechnology in drug delivery and tissue engineering: from discovery to applications

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

Active targeting schemes for nanoparticle systems in cancer therapeutics.

Impact of nanotechnology on drug delivery.

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

P304

19582-19585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA206998X

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Christopher S Chen

P577

2011-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51700951

http://www.w3.org/2001/XMLSchema#string

P698

21981330

http://www.w3.org/2001/XMLSchema#string

P921

P932

3295203

http://www.w3.org/2001/XMLSchema#string